Ebola

GlaxoSmithKline

Ebola vaccine from Glaxo passes early safety test

27/11/2014(0)
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists ... Read More
Sorkin-tmagArticle

Calculating the Grim Economic Costs of Ebola Outbreak

14/10/2014(0)
The topic everyone on Wall Street is discussing urgently but quietly isn’t the volatile global stock market. It is Ebola. While thousands of health care workers seek to control ... Read More
WallStreetSign

Asia down as Ebola scare hits Wall St., dollar rally on pause

02/10/2014(0)
Japanese stocks were knocked hard on Thursday as weak global manufacturing activity and an Ebola health scare in the United States spooked world markets, sending investors scurrying to the ... Read More
Broker Cyprus TopFX